In the evolving landscape of the China epilepsy market, the emphasis on innovative treatments is becoming more pronounced. With a market size expected to expand to USD 570 million by 2035, the anticipated CAGR of 5.39% highlights a growing public health concern. This growth is not merely a reflection of the increasing number of epilepsy cases but is also driven by the advancements in technology...